Pricing Log in Create free account

BioNTech SE Sponsored ADR (BNTX) vs Incyte Corporation (INCY)

BioNTech SE Sponsored ADR and Incyte Corporation are both Biotechnology companies. Incyte Corporation is the larger, with a market value of $24.1B against $21.6B — 1.1× the size. BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Incyte Corporation trades at 56.3×. Incyte Corporation grew revenue faster over the last twelve months: 24.9% against −22.7%. Incyte Corporation has the higher net margin (6.71% vs −63.8%) and the higher return on invested capital (21.6% vs −34.3%). Across the 18 metrics below, Incyte Corporation leads on 14 and BioNTech SE Sponsored ADR on 4.

Valuation

Metric BNTX INCY Biotechnology median
P/E n/m 56.33 10.26
P/S 7.88 4.00 9.18
P/B 1.05 4.26 2.05
Price to free cash flow n/m 35.34 24.81
EV/EBITDA n/m 27.88 0.65
EV/Sales 1.84 3.36 8.98
Earnings yield (7.93%) 1.78% (34.89%)
Free cash flow yield (2.44%) 2.83% (24.52%)

Profitability

Metric BNTX INCY Biotechnology median
Gross margin 74.59% 92.69% 65.16%
Operating margin (78.99%) 10.42% 0.00%
Net margin (63.77%) 6.71% 0.00%
Free cash flow margin (19.21%) 11.31% 0.00%
Return on equity (8.29%) 7.84% (50.12%)
Return on assets (7.22%) 5.92% (45.60%)
Return on invested capital (34.28%) 21.56% 0.00%

Growth

Metric BNTX INCY Biotechnology median
Revenue growth (TTM) (22.73%) 24.88% 6.26%
EPS growth (last fiscal year) (77.33%) 4,173.33% 29.88%
Revenue growth, 5-year CAGR 42.58% 14.03% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTX INCY Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 8.55 3.84 4.89
Net debt to EBITDA 14.29 (2.21) 1.01

Dividend

Metric BNTX INCY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BNTX INCY Biotechnology median
Market cap 21.57b 24.05b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack